| Literature DB >> 31252401 |
Masafumi Tetsuka1, Misato Tanakadate1.
Abstract
The bovine cumulus-oocyte complex (COC) is capable of converting cortisone, an inert glucocorticoid to active cortisol. This mechanism is mediated by 11β-hydroxysteroid oxidoreductase type 1 (HSD11B1), whose expression dramatically increases in the mature COC. In this study, we investigate the time course expression of HSD11B1 and the enzyme activity in the bovine COC undergoing maturation and fertilization in relation to key events taking place in the COC. Bovine COCs were subjected to in vitro maturation (IVM) and fertilization (IVF). The activities of HSD11B1 and HSD11B2, which mediates the opposite reaction, were measured using a radiometric conversion assay. In parallel studies, cumulus expansion, P4 production and the expression of genes associated with ovulation were measured. The reductive activity of HSD11B1 increased in the latter half of IVM and remained high during IVF, whereas the oxidative activity of HSD11B2 remained unchanged over both periods. Consequently, the net glucocorticoid metabolism in the bovine COC shifted from inactivation to activation around the time of ovulation and fertilization. The increase in HSD11B1 expression lagged behind that of P4 increase and cumulus expansion but ahead of the expressions of genes responsible for PGE2 synthesis. The reductive activity of HSD11B1 was well correlated with the cumulus expansion rate. This outcome indicates that the ability of the cumulus to activate glucocorticoids is related to its ability to synthesize hyaluronan. These results also indicate that the activation of HSD11B1 is an integral part of the sequential events taking place at the ovulation and fertilization in the bovine COC.Entities:
Keywords: HSD11B1; IVF; IVM; cumulus-oocyte complex; glucocorticoid
Year: 2019 PMID: 31252401 PMCID: PMC6652248 DOI: 10.1530/EC-19-0188
Source DB: PubMed Journal: Endocr Connect ISSN: 2049-3614 Impact factor: 3.335
Primers used for quantitative real-time PCR.
| Gene (bp) | Primer | Sequence (5′–3′) | GenBank no. | Positiona |
|---|---|---|---|---|
| F | AAGCAGACCAACGGGAGCATT | NM001123032.1 | 532–552 | |
| (111) | R | GGAGAAGAACCCATCCAGAGCA | 642–621 | |
| F | AGCCTGTGTGTGCCCAGTTC | BC120346.1 | 766–785 | |
| (62) | R | CCCAGGGTTTACTGCCAGCC | 916–897 | |
| F | CAGCAGAAGGGTGTCATCAGAG | NM174189.3 | 767–788 | |
| (149) | R | AGGACCTGGTTGATGATGGTCT | 915–894 | |
| F | CCCTGAAAGTGACTTGGTTCTTCA | NM176644.2 | 1209–1232 | |
| (118) | R | GTCAAACTTGTCCGGACTGGAG | 1326–1305 | |
| F | CCTTGTACACTTGTGCCCTGAG | NM174343.3 | 640–661 | |
| (118) | R | AACTTGCAGTGATTGGTCAGGA | 757–736 | |
| F | CCGGACAAGGAAGGAGATTTTT | NM001076883.1 | 95–116 | |
| (134) | R | TTGACGAGCTGGATATGCCTTT | 229–208 | |
| F | TTTCGGATGTGTCCAGTGC | NM174079.3 | 1362–1380 | |
| (142) | R | TCGGTTCGTTAGATGCCTGT | 1503–1484 | |
| F | CAAGGACCCAAAGGCACTGAAC | NM001075864.1 | 1464–1485 | |
| (136) | R | CGGCACGTCCTTCTCTGGTATT | 1599–1578 | |
| F | TCTACCCGCCTCATGTTCCT | NM174445.2 | 888–907 | |
| (108) | R | TGTGTTCCCGTAGCCAAATG | 995–976 | |
| F | CCGATGGCCCTTTGAGATTG | NM174443.2 | 538–557 | |
| (111) | R | CAAGGGACACACGGGGAAAC | 648–629 | |
| F | ACTCCGAGCACCACGCAAGA | NM001014894.1 | 945–964 | |
| (116) | R | TGGTGTTCCTGCGCATGGTCT | 1060–1040 | |
| F | GCGGCAGCCATCAGGGTGAG | NM001077866.1 | 17–36 | |
| (90) | R | AGGAAGCGCATCACGTCCGA | 106–87 | |
| F | GCCTTGTGCTTACCCACCAACAGTTC | NM001075742.1 | 1133–1158 | |
| (200) | R | TGTCTTCCTGAAACCCTTCAGAATAGGG | 1332–1305 |
aNucleotide position in the reported sequence.
CYP11A1, cytochrome P450, family 11, subfamily A, polypeptide 1; GFPT2, glutamine-fructose-6-phosphate transaminase 2; H6PDH, hexose-6-phosphate dehydrogenase; HAS2, hyaluronan synthase 2; HSD11B1, 11β-hydroxysteroid oxidoreductase type 1; HSD3B, hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1; PLA2G4A, phospholipase A2 group IVA; PTGES1, prostaglandin E2 microsomal synthase 1; PTGS2, prostaglandin-endoperoxide synthase 2; RPL15, ribosomal protein L15; RPL4, ribosomal protein L4; STAR, steroidogenic acute regulatory protein; TBP, TATA-box-binding protein.
Figure 1The reductive and oxidative activities of HSD11B in the bovine COC matured in vitro and cultured with and without spermatozoa. Bovine COCs (five COCs/well) were subjected to IVM for 21 h and then cultured in BO-containing radiolabeled cortisone/cortisol for 5 h with (IVF+) or without (IVF−) spermatozoa. (A) The morphology of COC before (IVM: 0 h) and after (IVM: 21 h) IVM, and after IVF (IVF: 5 h). (B) The reductive (cortisone to cortisol; black bars) and the oxidative (cortisol to cortisone; open bars) activities of HSD11B in the COC and spermatozoa during the 5 h IVF period. Mean ± s.e.m. (n = 4).
Figure 2The reductive and oxidative activities of HSD11B in the bovine COC during the 21 h of IVM and following the 5-h culture with and without spermatozoa. The bovine COCs (1 COC/well) were subjected to IVM for 21 h and then cultured for 5 h with (IVF+) or without (IVF−) spermatozoa. The reductive (cortisone to cortisol; black bars) and the oxidative (cortisol to cortisone; open bars) activities of HSD11B were measured for IVM (A) and IVF (B) periods. The time-adjusted activities of HSD11B during IVM and IVF periods are also shown (C). Mean ± s.e.m. (A: n = 16, B and C: n = 8).
Correlations between the size/expansion rate of the cumulus and the HSD11B activities in the bovine cumulus-oocyte complex (COC) during IVM.
| Variables | Adjusted R-squared ( | |
|---|---|---|
| Reductive activity | Oxidative activity | |
| Cumulus size 0 h (A) | −0.067 ( | −0.042 ( |
| Cumulus size 21 h (B) | 0.766 ( | −0.114 ( |
| Cumulus expansion rate (B/A) | 0.729 ( | −0.101 ( |
Figure 3The progesterone production (A) and cumulus expansion (B) of the bovine COC during the 24-h IVM period. The bovine COCs (1 COC/well) were subjected to IVM for up to 24 h, and the amount of P4 in the medium and size of the COC were measured at each time point. Mean ± s.e.m. (n = 5).
Figure 4Changes in the expression of genes responsible for glucocorticoid activation (HSD11B1; A, H6PDH; B), progesterone biosynthesis (STAR; C, CYP11A1; D, HSD3B1; E), cumulus expansion (GFPT2; F, HAS2; G) and PGE2 biosynthesis (PLA2G4A; H, PTGS2; I, PTGES1; J) in the bovine COC during the 24-h IVM period. The levels of gene expression were normalized to the geometric means of three stably expressed reference genes: TBP, RPL4 and RPL15. Mean ± s.e.m. (n = 5). Significant differences from the expression levels at 0 h. *P < 0.05, **P < 0.01.
Figure 5The expression of genes responsible for glucocorticoid activation (HSD11B1: A, H6PDH: B), progesterone biosynthesis (STAR: C, CYP11A1: D, HSD3B1: E), cumulus expansion (GFPT2: F, HAS2: G) and PGE2 biosynthesis (PLA2G4A: H, PTGS2: I, PTGES1: J) in the bovine COC matured in vitro and incubated with and without spermatozoa for 5 h. The gene expression levels were normalized to the geometric means of three stably expressed reference genes: TBP, RPL4 and RPL15. Mean ± s.e.m. (n = 4). *P < 0.05.